Literature DB >> 24217578

Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress.

Julia Leitman1, F Ulrich Hartl, Gerardo Z Lederkremer.   

Abstract

In Huntington's disease, as in other neurodegenerative diseases, it was initially thought that insoluble protein aggregates are the toxic species. However, growing evidence implicates soluble oligomeric polyglutamine-expanded huntingtin in cytotoxicity. Here we show that pathogenic huntingtin inhibits endoplasmic reticulum (ER)-associated degradation and induces ER stress before its aggregation into visible inclusions. All three branches of the unfolded protein response are activated. ER stress can be compensated by overexpression of p97/VCP, suggesting its sequestration by pathogenic huntingtin as a main cause. Stress correlates with the presence of huntingtin oligomers and is independent of continual huntingtin synthesis. Stress levels, measured in striatal neurons, are stabilized but only slowly subside on huntingtin aggregation into inclusions. Our results can be explained by the constant conversion of huntingtin monomers to toxic oligomers; large aggregates sequester the former, precluding further conversion, whereas pre-existing toxic oligomers are only gradually depleted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24217578     DOI: 10.1038/ncomms3753

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  69 in total

1.  Improved proteostasis in the secretory pathway rescues Alzheimer's disease in the mouse.

Authors:  Yajing Peng; Mi Jin Kim; Rikki Hullinger; Kenneth J O'Riordan; Corinna Burger; Mariana Pehar; Luigi Puglielli
Journal:  Brain       Date:  2016-01-19       Impact factor: 13.501

2.  The Cdc48 Complex Alleviates the Cytotoxicity of Misfolded Proteins by Regulating Ubiquitin Homeostasis.

Authors:  Ryan Higgins; Marie-Helene Kabbaj; Delaney Sherwin; Lauren A Howell; Alexa Hatcher; Robert J Tomko; Yanchang Wang
Journal:  Cell Rep       Date:  2020-07-14       Impact factor: 9.423

Review 3.  Therapeutic approaches to Huntington disease: from the bench to the clinic.

Authors:  Nicholas S Caron; E Ray Dorsey; Michael R Hayden
Journal:  Nat Rev Drug Discov       Date:  2018-09-21       Impact factor: 84.694

4.  Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice.

Authors:  Natalie M Frederick; Julie Bertho; Kishan K Patel; Geraldine T Petr; Ekaterina Bakradze; Sylvia B Smith; Paul A Rosenberg
Journal:  Neurochem Int       Date:  2014-07-05       Impact factor: 3.921

Review 5.  The emerging role of the first 17 amino acids of huntingtin in Huntington's disease.

Authors:  James R Arndt; Maxmore Chaibva; Justin Legleiter
Journal:  Biomol Concepts       Date:  2015-03

6.  The VCP/p97 and YOD1 Proteins Have Different Substrate-dependent Activities in Endoplasmic Reticulum-associated Degradation (ERAD).

Authors:  Linda Sasset; Gianluca Petris; Francesca Cesaratto; Oscar R Burrone
Journal:  J Biol Chem       Date:  2015-10-13       Impact factor: 5.157

Review 7.  Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers.

Authors:  Alexander G Thompson; Elizabeth Gray; Sabrina M Heman-Ackah; Imre Mäger; Kevin Talbot; Samir El Andaloussi; Matthew J Wood; Martin R Turner
Journal:  Nat Rev Neurol       Date:  2016-05-13       Impact factor: 42.937

8.  Identification of distinct conformations associated with monomers and fibril assemblies of mutant huntingtin.

Authors:  Jan Ko; J Mario Isas; Adam Sabbaugh; Jung Hyun Yoo; Nitin K Pandey; Anjalika Chongtham; Mark Ladinsky; Wei-Li Wu; Heike Rohweder; Andreas Weiss; Douglas Macdonald; Ignacio Munoz-Sanjuan; Ralf Langen; Paul H Patterson; Ali Khoshnan
Journal:  Hum Mol Genet       Date:  2018-07-01       Impact factor: 6.150

9.  Site-specific ubiquitination of pathogenic huntingtin attenuates its deleterious effects.

Authors:  Vicky Hakim-Eshed; Ayub Boulos; Chen Cohen-Rosenzweig; Libo Yu-Taeger; Tamar Ziv; Yong Tae Kwon; Olaf Riess; Hoa Huu Phuc Nguyen; Noam E Ziv; Aaron Ciechanover
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-16       Impact factor: 11.205

10.  FGF2 and dual agonist of NCAM and FGF receptor 1, Enreptin, rescue neurite outgrowth loss in hippocampal neurons expressing mutated huntingtin proteins.

Authors:  Mirolyuba Ilieva; Troels T Nielsen; Tanja Michel; Stanislava Pankratova
Journal:  J Neural Transm (Vienna)       Date:  2019-09-09       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.